$29.08
$53.8
Videos Only NO PDFS Description Include: 18 videos Information: This conference gives the platform to have open dialogue, discussion, and debate about the etiology, progression, and therapeutic approaches for a better understanding of cognitive wellness. This event will host interactive courses that will allow time for Q&A after each lecture, and we will encourage active participation using the audience response/polling system to incorporate a self-assessment where participants can see how their answer choices compare to their peers. There will be smaller group breakout sessions for participants to attend creating a lively, respectful atmosphere, engaging scientists, and clinicians around the topics of Neurosciences in multiple capacities. We will be featuring didactic/case presentations and poster sessions led by experts in neuroscience and related fields. Specifically, this event focuses on current advances in biomarker assessment, treatment with medication interventions, and prevention of neurodegenerative diseases, such as Dementia of Alzheimer’s disease, parkinsonism, multiple sclerosis and neuromuscular diseases, Additional topics of the symposium include impacts of sleep, Normal Pressure Hydrocephalus, epilepsy and research trials. Learning Objectives Determine effective clinical strategies in the management of Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Parkinson’s, and headaches/migraines. Identify early and progressive signs in disorders associated with aging, including Dementia, Alzheimer’s, and Parkinson’s. Discuss current research developments and treatment options specific to neurological diseases in both common and complex clinical cases. Analyze how lifestyle choices, genetic predispositions, and etiological factors contribute to the onset of neurological diseases. Determine effective clinical strategies for treating neurological disorders, including strokes, Polyneuropathy, and neurological pain. Discuss research developments in clinical cases involving the identification and management of Multiple Sclerosis (MS), Epilepsy, and neuroimmunology disease. Identify the value and importance of each team member’s role in the treatment of neurological disorders, including neurology consultations performed by Advanced Practice Providers (APPs). Identify recent treatment innovations and the best practices in diagnostic testing for neurodegenerative diseases and neurological disorders. The AdventHealth NeuroSynergy 2025 conference is best for neurologists, neurosurgeons, neuroscientists, family physicians, and allied health professionals who want evidence‑based updates on cognitive wellness, neurodegenerative diseases, and innovative approaches to diagnostics and treatment. It is designed for clinicians and researchers seeking interdisciplinary collaboration and practical strategies in modern neurological care. Who Should Attend Neurologists & neurosurgeons managing patients with ALS, MS, Parkinson’s, dementia, epilepsy, and other neurological disorders. Family physicians & internists who encounter cognitive decline and neurological conditions in primary care. Neuroscientists & researchers studying brain injury, neuroimmunology, and cognitive health. Residents & fellows in neurology, neurosurgery, psychiatry, or neuroscience seeking advanced exposure. Allied health professionals (rehabilitation specialists, neuropsychologists, therapists) involved in multidisciplinary care. What You’ll Learn Cognitive wellness focus: causes, progression, and therapeutic approaches to cognitive health. Disease updates: latest strategies in ALS, MS, Parkinson’s, dementia, epilepsy, and related conditions. Diagnostics & treatment: innovative approaches in neuroimmunology, imaging, and clinical management. Interdisciplinary collaboration: team‑based neurology care and integration across specialties. Educational formats: didactic presentations, case studies, poster sessions, and breakout discussions. Title Runtime Understanding Amyotrophic Lateral Sclerosis (ALS) 28:18 Advances in Alzheimer’s Disease Diagnosis and Therapeutics 25:35 Cognitive Impairment Cases 30:07 Headache Basics 14:58 Preventive Treatment of Migraine 16:13 Management Considerations in Cortical Superficial Siderosis 19:49 Vivistim for Chronic Ischemic Stroke Patients 14:53 Parkinson’s Disease: Non-Motor Symptoms (Case Discussion) 46:32 Deep Brain Stimulation – MR Guided Focused Ultrasound 23:56 NeuroSynergy Panel Discussion: Part 1 23:48 2024 Revisions to McDonald Criteria 14:25 What’s Next in Multiple Sclerosis? 15:23 Bevacizumab for Treatment Effects: Pearls for Good Practice 31:01 Interesting Movement Disorder Case Studies 23:30 Neurovascular Compression Syndromes & Craniofacial Pain 30:15 Emergency Department Stroke Process 17:49 Rehab Services for Stroke Care 12:24 NeuroSynergy Panel Discussion: Part 2 06:41
Neurology
